Komori
Financial results presentation5571Excite Holdings Co.,Ltd.Information and Communications, Services and Others

Financial Results Presentation Materials for the First Quarter of the Fiscal Year Ending March 2026

For the first quarter of the fiscal year ending March 2026, revenue increased substantially due to the consolidation of the Medical business and its growth, while operating profit and net income declined due to lower profit in the Media business resulting from lower advertising rates and the recognition of extraordinary losses. The company also changed its reporting to disclose the Medical business as a separate reportable segment.

Worth reading
56In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
532
¥ million (year-on-year increase in consolidated net sales)
Wording
Conditional
How definitive the wording is.

Contents of this document

Financial results presentationFirst quarter of the fiscal year ended March 202611 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥2,552 million+26.4%
Operating profit¥71 million-29.7%
Ordinary income¥54 million-45.0%
Net income¥-22 million
Gross Profit Margin58.6 %
Operating profit margin2.8 %
Results for the three months of the current quarter売上高2,552百万円、売上総利益1,495百万円、EBITDA170百万円、営業利益71百万円、経常利益54百万円、親会社株主に帰属する四半期純利益▲22百万円。いずれも1Q連結会計期間（4-6月）の数値。
Full-year earnings forecast
Net Sales
¥11,000 million
EBITDA
¥1,200 million
Operating profit
¥610 million
Ordinary income
¥560 million
Profit attributable to owners of the parent
¥320 million
メディカル事業売上高
¥3,000 million
Platform business sales
¥3,400 million
ブロードバンド事業売上高
¥3,600 million
SaaS・DX事業売上高
¥1,000 million
Progress against full-year forecast　通期の予想に対して、いまどこまで進んだかの割合です。
Net Sales23.2
EBITDA14.2
Operating profit11.7
Ordinary income9.7
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
売上高は想定通りのスタート
Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
  • メディアサービス営業利益の減少¥-80 million
  • Head Office Relocation Costs¥68 million
  • Business Exit Losses¥33 million
  • Increase in personnel expenses¥33 million
Assumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.
為替レート、原材料価格、金利などの数値前提はNot disclosed。メディカル事業の継続成長、メディア事業の回復途上による減収、10ギガ回線の強化、SaaSの増収などの定性的方針を記載。
New initiatives
  • Medical Operations Disclosed as a Separate Reportable Segment
  • 美容・健康を中心とした診療科目の拡大
  • クリニック数・配送エリアの拡大
  • 美容・健康関連企業とのアライアンスによる送客チャネル拡大
  • BB.excite光10Gの提供開始
  • ZVC JAPANとのSharelyのISVパートナー契約
  • インティメート・マージャーとのFanGrowthの業務提携
Key KPIsA metric the company considers important as a management benchmark.
  • ONE MEDICAL 6月GMV¥239 million
  • カウンセリングサービス相談回数
    Year on year against the same period last year-2.8%
  • Repeat customer ratio69.2 %
  • Average monthly page views for Media Services
    Year on year against the same period last year+17.3%
  • 光回線等の月間平均課金会員数61,230 people
    Year on year against the same period last year-2.6%
  • SaaS business ARR¥465 million
    Year on year against the same period last year+29.4%
Unit price and quantity metricsThese figures show sales broken down by price and volume.
  • 光回線等の月間平均課金会員数61,230 people
    Year on year against the same period last year-2.6%
  • Average monthly page views for Media Services
    Year on year against the same period last year+17.3%
  • カウンセリングサービス相談回数
    Year on year against the same period last year-2.8%
Segment results
Medical Business
Net Sales
¥576 million+1,412.6%
Operating profit
¥-41 million
Platform Business
Net Sales
¥831 million+3.4%
Operating profit
¥68 million-45.1%
Broadband business
Net Sales
¥906 million-3.3%
Operating profit
¥139 million-5.1%
SaaS and DX Business
Net Sales
¥238 million-0.8%
Operating profit
¥-15 million
Medium-term management plan targets
中期経営計画『EXCITE300』に言及しているが、目標値・目標年度はNot disclosed。
Financial targets
Equity ratio
Actual results33.1 %
ROE
Actual results-0.7 %
Market Size / Share
  • Cosmetic medicine market size¥6,300 100 million
  • 2024年インターネット広告費¥3.6 1 trillion
    Year on year against the same period last year+9.6%
Number of employees
Number of Employees255 people
As ofEnd of June 2025
Hiring plan採用による組織体制強化に言及
Contents of this document
ItemDetails
Document typeFinancial results presentation
Fiscal Period CoveredFirst quarter of the fiscal year ended March 2026
Net Sales¥2,552 million (YoY +26.4%)
Operating profit¥71 million (YoY -29.7%)
Ordinary income¥54 million (YoY -45.0%)
Net income¥-22 million
Gross Profit Margin58.6 %
Operating profit margin2.8 %
Results for the three months of the current quarter売上高2,552百万円、売上総利益1,495百万円、EBITDA170百万円、営業利益71百万円、経常利益54百万円、親会社株主に帰属する四半期純利益▲22百万円。いずれも1Q連結会計期間（4-6月）の数値。
Full-year earnings forecastNet Sales ¥11,000 million / EBITDA ¥1,200 million / Operating profit ¥610 million / Ordinary income ¥560 million / Profit attributable to owners of the parent ¥320 million / メディカル事業売上高 ¥3,000 million / Platform business sales ¥3,400 million / ブロードバンド事業売上高 ¥3,600 million / SaaS・DX事業売上高 ¥1,000 million
Progress against full-year forecastNet Sales 23.2 / EBITDA 14.2 / Operating profit 11.7 / Ordinary income 9.7 / Profit attributable to owners of the parent Not disclosed
Self-assessment against the plan売上高は想定通りのスタート
Segment resultsMedical Business Net Sales ¥576 million (YoY +1,412.6%) / Operating profit ¥-41 million / Platform Business Net Sales ¥831 million (YoY +3.4%) / Operating profit ¥68 million (YoY -45.1%) / Broadband business Net Sales ¥906 million (YoY -3.3%) / Operating profit ¥139 million (YoY -5.1%) / SaaS and DX Business Net Sales ¥238 million (YoY -0.8%) / Operating profit ¥-15 million
Breakdown of Factors Affecting the ChangeFactors メディアサービス営業利益の減少 / Amount ¥-80 million, Factors Head Office Relocation Costs / Amount ¥68 million, Factors Business Exit Losses / Amount ¥33 million, Factors Increase in personnel expenses / Amount ¥33 million
Key KPIsIndicator name ONE MEDICAL 6月GMV / Value ¥239 million / Year on year against the same period last year Not disclosed, Indicator name カウンセリングサービス相談回数 / Value Not disclosed / Year on year against the same period last year -2.8 times, Indicator name Repeat customer ratio / Value 69.2 % / Year on year against the same period last year Not disclosed, Indicator name Average monthly page views for Media Services / Value Not disclosed / Year on year against the same period last year 17.3 million PVs/month, Indicator name 光回線等の月間平均課金会員数 / Value 61,230 people / Year on year against the same period last year -2.6 people, Indicator name SaaS business ARR / Value ¥465 million / Year on year against the same period last year ¥29.4 million
Unit price and quantity metricsIndicator name 光回線等の月間平均課金会員数 / Value 61,230 people / Year on year against the same period last year -2.6 people, Indicator name Average monthly page views for Media Services / Value Not disclosed / Year on year against the same period last year 17.3 million PVs/month, Indicator name カウンセリングサービス相談回数 / Value Not disclosed / Year on year against the same period last year -2.8 times
Number of employeesNumber of Employees 255 people / As of End of June 2025 / Change during the period Not disclosed / Hiring plan 採用による組織体制強化に言及
Assumptions Underlying the Business Outlook為替レート、原材料価格、金利などの数値前提はNot disclosed。メディカル事業の継続成長、メディア事業の回復途上による減収、10ギガ回線の強化、SaaSの増収などの定性的方針を記載。
Medium-term management plan targets中期経営計画『EXCITE300』に言及しているが、目標値・目標年度はNot disclosed。
Financial targetsEquity ratio Actual results 33.1 % / ROE Actual results -0.7 % / Target Not disclosed
Market Size / ShareSubject Cosmetic medicine market size / Value ¥6,300 100 million, Subject 2024年インターネット広告費 / Value ¥3.6 1 trillion / Year on year against the same period last year ¥9.6 1 trillion
New initiativesMedical Operations Disclosed as a Separate Reportable Segment, 美容・健康を中心とした診療科目の拡大, クリニック数・配送エリアの拡大, 美容・健康関連企業とのアライアンスによる送客チャネル拡大, BB.excite光10Gの提供開始, ZVC JAPANとのSharelyのISVパートナー契約, インティメート・マージャーとのFanGrowthの業務提携
Items this document does not state (9)
Selling, general and administrative expensesNumber of stores and locationsRisk amount incorporated into the outlookAnnual DividendPayout ratioAcquisition of treasury sharesCapital expendituresOrders received and order backlogKey points of the Q&A

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

売上高はONE MEDICALを含むメディカル事業の伸長により増加した。営業利益は、カウンセリング事業の増益があったものの、メディア事業で広告単価が下落し、前年同期比80百万円減益となった影響で減少した。親会社株主に帰属する四半期純利益は、本社移転費用68百万円と事業撤退損33百万円を特別損失に計上したため赤字となった。報告セグメントの変更は、メディカル領域を中心とした成長を見込み、中期経営計画の進捗と組織体制・情報開示の区分を一致させるためとしている。

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Financial Results Presentation Materials for the First Quarter of the Fiscal Year Ending March 2026 | Excite Holdings Co.,Ltd. (5571) timely disclosure | Komori